Categorized | Business, Health, Sanatoga, Social

Sanatoga Ridge Hosts ‘Making Healthy Homes’ Talk

Posted on 30 March 2011. Tags:

SANATOGA PA – “Creating Healthy Homes,” a free lunch-and-learn presentation intended to show participants how to make their homes healthier and more energy efficient, will be held next Wednesday (April 6, 2011) beginning at noon in the Sanatoga Ridge Community Center, 2461 E. High St., Pottstown PA. Reservations for the event are required, however, and must be made by calling 610-323-5190 by Friday (April 1).

Worsening allergies, containing the spread of colds and other illnesses, and nighttime sleep all are spring-related topics the discussion will address. Doors will open at 11:30 a.m.

Share

One Response to “Sanatoga Ridge Hosts ‘Making Healthy Homes’ Talk”

Trackbacks/Pingbacks

  1. Wednesday’s Headlines In The Post | The Sanatoga Post says:
    March 30, 2011 at 6:59 am

    [...] Sanatoga Ridge Hosts ‘Making Healthy Homes’ Talk Spring is a time for allergies, germ-spreading, and poor sleep for some. A lecture next week at Sanatoga Ridge Community aims to offer advice to help relieve those problems. [...]


From Our Sponsors

RSS Health News

  • Exclusive: 'Workplace wellness' fails bottom line, waistlines - RAND May 24, 2013
    NEW YORK (Reuters) - A long-awaited report on workplace wellness programs, which has still not been publicly released, delivers a blow to the increasingly popular efforts, Reuters has learned, casting doubt on a pillar of the Affordable Care Act and a favorite of the business community. […]
  • Certain chronic pain may raise suicide risk May 24, 2013
    NEW YORK (Reuters Health) - Back pain, migraine and other types of chronic pain without a known physical cause - and therefore little prospect for relief - were associated with an increased risk of suicide in a new study of U.S. veterans. […]
  • Some with defibrillators may safely play sports May 24, 2013
    NEW YORK (Reuters Health) - Despite expert guidelines advising against intense sports activity for people with implanted heart defibrillators, a new study suggests that some can compete without serious consequences. […]
  • New U.S. fears emerge over tainted compounded steroids May 24, 2013
    (Reuters) - The Food and Drug Administration said on Friday it has received seven reports of illnesses in patients who took steroid injections compounded by a pharmacy in Tennessee. […]
  • Valeant near deal to acquire Bausch & Lomb: source May 24, 2013
    NEW YORK (Reuters) - Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch & Lomb Holdings Inc from Warburg Pincus LLC for about $9 billion, a person familiar with the matter said on Friday. […]
  • New bird flu may be capable of human to human spread - study May 24, 2013
    HONG KONG (Reuters) - The new H7N9 bird flu virus can be transmitted between mammals not only via direct contact but also in airborne droplets, and may be capable of spreading from person to person, Chinese and American researchers have found. […]
  • C-sections tied to child obesity May 24, 2013
    NEW YORK (Reuters Health) - More babies born via cesarean section grow up to be heavy kids and teens than those delivered vaginally, according to a new study of more than 10,000 UK infants. […]
  • WHO to help Saudi Arabia investigate coronavirus before haj May 24, 2013
    GENEVA (Reuters) - The World Health Organization (WHO) said on Friday that it would help Saudi Arabia dig deeper into deadly outbreaks of a new SARS-like virus to draw up advice ahead of the annual haj pilgrimage, which attracts millions of Muslims. […]
  • Novo obesity drug could launch in U.S. end 2014 May 24, 2013
    COPENHAGEN (Reuters) - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the medicine's commercial potential. […]
  • Aveo says partner Astellas will not seek EU nod for kidney cancer drug May 23, 2013
    (Reuters) - Aveo Pharmaceuticals Inc said it was informed by its partner Astellas Pharma Inc that the Japanese company would not be seeking marketing approval for their experimental kidney cancer drug in Europe. […]

The Posts On Health At Twitter